1.Distinct Contributions of Alpha and Beta Oscillations to Context-Dependent Visual Size Perception.
Neuroscience Bulletin 2024;40(12):1875-1885
Previous studies have proposed two cognitive mechanisms responsible for the Ebbinghaus illusion effect, i.e., contour interaction and size contrast. However, the neural underpinnings of these two mechanisms are largely unexplored. The present study introduced binocular depth to the Ebbinghaus illusion configuration and made the central target appear either in front of or behind the surrounding inducers in order to disturb size contrast instead of contour interaction. The results showed that the illusion effect, though persisted, was significantly reduced under the binocular depth conditions. Notably, the target with a larger perceived size reduced early alpha-band power (8-13 Hz, 0-100 ms after stimulus onset) at centroparietal sites irrespective of the relative depth of the target and the inducers, with the parietal alpha power negatively correlated with the illusion effect. Moreover, the target with a larger perceived size increased the occipito-parietal beta-band power (14-25 Hz, 200-300 ms after stimulus onset) under the no-depth condition, and the beta power was positively correlated with the illusion effect when the depth conditions were subtracted from the no-depth condition. The findings provided neurophysiological evidence in favor of the two cognitive mechanisms of the Ebbinghaus illusion by revealing that early alpha power is associated with low-level contour interaction and late beta power is linked to high-level size contrast, supporting the claim that neural oscillations at distinct frequency bands dynamically support different aspects of visual processing.
Humans
;
Alpha Rhythm/physiology*
;
Female
;
Male
;
Size Perception/physiology*
;
Young Adult
;
Adult
;
Beta Rhythm/physiology*
;
Photic Stimulation/methods*
;
Illusions/physiology*
;
Optical Illusions/physiology*
;
Depth Perception/physiology*
2.Wernekink Commissure Syndrome With Hallucinations and Involuntary Groping:Report of One Case.
Lu-Lu DONG ; Lu-Lu WANG ; Xue-Qian ZHANG ; Wei-Na GUO ; Tian-Jun WANG
Acta Academiae Medicinae Sinicae 2023;45(2):346-350
Wernekink commissure syndrome is a rare midbrain syndrome with bilateral cerebellar dysfunction,eye movement disorder,and palatal myoclonus.Few cases of this syndrome have been reported in China,let alone those combined with hallucinations and involuntary groping.This paper reports the diagnosis and treatment of a case of Wernekink commissure syndrome with hallucinations and involuntary groping,aiming to enrich the knowledge about this disease for clinicians.
Humans
;
Mesencephalon
;
Ocular Motility Disorders/diagnosis*
;
Spinal Cord
;
Syndrome
;
Hallucinations
4.Psychotic Symptoms of Hashimoto's Encephalopathy: A Diagnostic Challenge
Monisha K SAVARIMUTHU ; Sherab TSHERINGLA ; Priya MAMMEN
Journal of the Korean Academy of Child and Adolescent Psychiatry 2019;30(1):42-44
Hashimoto's encephalopathy (HE) is a rare and underdiagnosed neuropsychiatric illness. We present the case of a 17-year-old girl who was admitted to a tertiary-care psychiatric center with acute onset psychosis and fever. Her psychotic symptoms were characterized by persecutory and referential delusions, as well as tactile and visual hallucinations. Her acute behavioral disturbance warranted admission and treatment in a psychiatric setting (risperidone tablets, 3 mg/day). She had experienced an episode of fever with a unilateral visual acuity defect approximately 3 years before admission, which was resolved with treatment. Focused clinical examination revealed an enlarged thyroid, and baseline blood investigations, including thyroid function test results were normal. Abnormal laboratory investigations revealed elevated anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) levels (anti-TPO of 480 IU/mL; anti-TG of 287 IU/mL). Results of other investigations for infection, including cerebrospinal fluid examination, electroencephalography, and brain magnetic resonance imaging were normal. She was diagnosed with HE and was treated with intravenous corticosteroids (methylprednisolone up to 1 g/day; tapered and discontinued after a month). The patient achieved complete remission of psychotic symptoms and normalization of the anti-thyroid antibody titers. Currently, at the seventh month of follow-up, the patient is doing well. This case highlights the fact that in the absence of well-defined clinical diagnostic criteria, a high index of suspicion is required for early diagnosis of HE. Psychiatrists need to explore for organic etiologies when dealing with acute psychiatric symptoms in a younger age group.
Adolescent
;
Adrenal Cortex Hormones
;
Brain
;
Brain Diseases
;
Cerebrospinal Fluid
;
Delusions
;
Early Diagnosis
;
Electroencephalography
;
Female
;
Fever
;
Follow-Up Studies
;
Hallucinations
;
Humans
;
Magnetic Resonance Imaging
;
Methylprednisolone
;
Peroxidase
;
Psychiatry
;
Psychotic Disorders
;
Risperidone
;
Tablets
;
Thyroid Function Tests
;
Thyroid Gland
;
Visual Acuity
5.Two Cases of Opioid-Induced Hyperalgesia in Cancer Patients Treated with Opioids for Pain Management
Sukchul HONG ; Jung Hye KWON ; Su Jung HAN
Korean Journal of Hospice and Palliative Care 2019;22(2):100-104
Opioids are important drugs for the management of severe cancer pain without a ceiling effect. However, opioid administration leads to dose-limiting complications including drowsiness, hallucinations, delirium, respiratory depression, cognitive impairment, seizure, myoclonus, and hyperalgesia. Opioid-induced hyperalgesia (OIH) is a paradoxical phenomenon as opioid exposure increases pain sensitivity. Reducing or stopping opioids, opioid rotation, or co-administration of N-methyl-D-aspartate (NMDA) antagonists have been suggested for the management of OIH. In this study, we report two clinical cases of successful management of OIH in cancer pain patients that were treated with opioids.
Analgesics, Opioid
;
Cognition Disorders
;
Delirium
;
Hallucinations
;
Humans
;
Hyperalgesia
;
Myoclonus
;
N-Methylaspartate
;
Pain Management
;
Respiratory Insufficiency
;
Seizures
;
Sleep Stages
6.Effect of tDCS on Aberrant Functional Network Connectivity in Refractory Hallucinatory Schizophrenia: A Pilot Study
Youngwoo Bryan YOON ; Minah KIM ; Junhee LEE ; Kang Ik K CHO ; Seoyeon KWAK ; Tae Young LEE ; Jun Soo KWON
Psychiatry Investigation 2019;16(3):244-248
We aim to investigate the effect of fronto-temporal transcranial direct current stimulation (tDCS) on the interactions among functional networks and its association with psychotic symptoms. In this pilot study, we will determine possible candidate functional networks and an adequate sample size for future research. Seven schizophrenia patients with treatment-refractory auditory hallucinations underwent tDCS twice daily for 5 days. Resting-state fMRI data and measures of the severity of psychotic symptoms were acquired at baseline and after completion of the tDCS sessions. At baseline, decreased functional network interaction was negatively correlated with increased hallucinatory behavior. After tDCS, the previously reduced functional network connectivity significantly increased. Our results showed that fronto-temporal tDCS could possibly remediate aberrant hallucination-related functional network interactions in patients with schizophrenia.
Hallucinations
;
Humans
;
Magnetic Resonance Imaging
;
Neuroimaging
;
Pilot Projects
;
Sample Size
;
Schizophrenia
;
Transcranial Direct Current Stimulation
7.Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine
In Won CHUNG ; Seong Hoon JEONG ; Hee Yeon JUNG ; Tak YOUN ; Se Hyun KIM ; Yong Sik KIM
Psychiatry Investigation 2019;16(5):403-406
This study explored long-term changes in self-report auditory verbal hallucinations (AVHs) among patients with schizophrenia taking clozapine. Forty-four patients who were evaluated more than twice and were above the mild severity category on the Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ) were enrolled. The mean observation period was 492.5±350.1 days (median, 452 days). The mean total, physical, and emotional factor scores on the HPSVQ were significantly reduced from baseline to the final observations except for one item “interference with life,” which was not significantly reduced. Regarding the time-dependent longitudinal changes modeled using linear mixed-effect regression, the total and physical factor scores showed significant changes during the first year, but the emotional factor score did not satisfy a more stringent level of significance. Female gender was negatively associated with the reduction in total and physical factor scores. The duration of treatment with clozapine also had a negative relationship with the reductions in all three scores.
Clozapine
;
Female
;
Hallucinations
;
Humans
;
Schizophrenia
;
Voice
8.Effectiveness of Family-Engaged Multidimensional Team Planning and Management for Recovery in Patients With Severe Stroke and Low Functional Status
Fukumi HIRAGAMI ; Shogo HIRAGAMI ; Yu INOUE
Annals of Rehabilitation Medicine 2019;43(5):581-591
OBJECTIVE: To evaluate the effectiveness of family-engaged multidimensional team planning and management for patients with severe stroke and low functional status and to identify factors predictive of improved outcome at 1 month after admission. METHODS: We retrospectively evaluated 50 patients who underwent family-engaged multidimensional rehabilitation for recovery from severe stroke due to primary unilateral cerebral lesions. The rehabilitation consisted of three phases: comprehensive multidimensional assessment, intensive rehabilitation, and evaluation. Functional Independence Measure (FIM) scores were calculated and used to predict the patients’ status at discharge. RESULTS: Although all FIM scores significantly improved after 1 month of rehabilitation, the motor FIM (mFIM) score improved the most (from 20.5±1.0 to 32.6±2.0). The total FIM (tFIM) and mFIM scores continued to improve from the first month to discharge (mean mFIM efficiency, 0.33). The high-efficiency patient group (mFIM efficiency ≥0.19) had a significantly higher discharge-to-home rate (44% vs. 13%), lower frequency of hemispatial neglect, and more severe finger numbness than the low-efficiency patient group (mFIM efficiency <0.19). The regression analyses revealed that besides lower mFIM and cognitive FIM scores at admission, unilateral spatial neglect, systemic comorbidities, and age were predictive of worse 1-month outcomes and tFIM scores (conformity, R²=0.78; predictive power, Akaike information criterion value=202). CONCLUSION: Family-engaged multidimensional team planning and management are useful for patients with severe stroke and low functional status. Furthermore, FIM scores at admission, age, unilateral spatial neglect, and systemic comorbidities should be considered by rehabilitation teams when advising caregivers on the probability of favorable outcomes after rehabilitation.
Caregivers
;
Cerebrovascular Disorders
;
Comorbidity
;
Fingers
;
Humans
;
Hypesthesia
;
Perceptual Disorders
;
Rehabilitation
;
Retrospective Studies
;
Stroke
;
Symptom Assessment
9.Naltrexone-associated Visual Hallucinations: A Case Report
Dae Bo LEE ; Young Sup WOO ; Won Myong BAHK
Clinical Psychopharmacology and Neuroscience 2019;17(2):329-331
Naltrexone is a competitive antagonist of μ, δ, and κ opioid receptors. Naltrexone has been investigated for use an as anti-obesity agent in both the general population and in patients with severe mental illness, including schizophrenia. In patients with schizophrenia, however, potential psychotic symptoms due to adverse effects of naltrexone have not been investigated. Our case study, a relevant case report, and some related articles suggest that naltrexone might be associated with the emergence of visual hallucinations, which clinicians should be aware of.
Drug-Related Side Effects and Adverse Reactions
;
Hallucinations
;
Humans
;
Naltrexone
;
Narcotic Antagonists
;
Receptors, Opioid
;
Schizophrenia
10.Musical Hallucination Caused by Ceftazidime in a Woman with a Hearing Impairment
Clinical Psychopharmacology and Neuroscience 2019;17(2):326-328
Musical hallucinations remain a poorly understood clinical phenomenon, possibly because these types of hallucination have multiple causes and are rarely the focus of published reports. Here, the case of a 51-year-old female patient with a hearing impairment who developed musical hallucinations during treatment with ceftazidime, a third-generation cephalosporin, is presented. She responded to the discontinuation of ceftazidime and the initiation of low-dose olanzapine treatment. Musical hallucinations associated with ceftazidime are very rare, and the mechanisms underlying its occurrence remain unknown. Further studies will be necessary to determine the pathophysiology of adverse psychiatric reactions associated with ceftazidime.
Ceftazidime
;
Drug-Related Side Effects and Adverse Reactions
;
Female
;
Hallucinations
;
Hearing Loss
;
Hearing
;
Humans
;
Middle Aged
;
Music

Result Analysis
Print
Save
E-mail